Latest filing published 15 Sept 2026 for Wuhan YZY Biopharma Co., Ltd. - B - H Shares, €9.5M.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Zhou Pengfei: trading record in brief
Zhou Pengfei, listed as chief executive, has filed trades across 2 companies (mainly through HKEX), most often in Wuhan YZY Biopharma Co., Ltd. - B and Wuhan YZY Biopharma Co., Ltd. - B - H Shares. The record holds 3 filings, for trades running from 30 March 2026 to 30 August 2026.
Both buying and selling appear: 2 purchases worth €9.5M, against 1 sale. The totals do not cover 2 filings with an undisclosed amount. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
The newest entry dates from 15 September 2026: an open-market purchase of €9.5M, in Wuhan YZY Biopharma Co., Ltd. - B - H Shares. Filings reach the HKEX feed a median of 2 days after the trade. This delay matters because a trade only becomes useful information once it is public. These figures are compiled from regulatory filings published by HKEX. They describe what insiders did and are not a recommendation.
Companies and markets linked to Zhou Pengfei
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 35,592,400 shares@ HK$2.43100.0% of flowShareXHKGHKEX:DA20260914E00537Canonical exit: 28 Nov 2026 (T+90)
- 54,262,305 sharesShareXHKGHKEX:DA20260331E00391Canonical exit: 28 Jun 2026 (T+90)
- 54,262,305 sharesShareXHKGHKEX:DA20260331E00390
3 of 2 declarations